output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Acne Vulgaris [drug therapy]; 2. Body Mass Index; 3. Cardiovascular Diseases [prevention & control]; 4. Contraceptives, Oral, Combined [adverse effects, *therapeutic use]; 5. Drug Therapy, Combination; 6. Endometrial Neoplasms [prevention & control]; 7. Hirsutism [*drug therapy]; 8. Hypoglycemic Agents [*therapeutic use]; 9. Menstruation Disturbances [*drug therapy]; 10. Metformin [adverse effects, *therapeutic use]; 11. Polycystic Ovary Syndrome [complications, *drug therapy]; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetaminophen [administration & dosage, adverse effects]; 2. Acute Disease; 3. Administration, Oral; 4. Analgesics [*administration & dosage, adverse effects]; 5. Analgesics, Opioid [administration & dosage, adverse effects]; 6. Anti-Inflammatory Agents, Non-Steroidal [*administration & dosage, adverse effects]; 7. Bias; 8. Contusions [*drug therapy]; 9. Pain [drug therapy]; 10. Randomized Controlled Trials as Topic; 11. Soft Tissue Injuries [*drug therapy]; 12. Sprains and Strains [*drug therapy]; 13. Time-to-Treatment; | Provide MESH terms for the study
Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Anti-Inflammatory Agents, Non-Steroidal [*administration & dosage, adverse effects]; 3. Bias; 4. Colitis, Ulcerative [*drug therapy]; 5. Drug Administration Schedule; 6. Induction Chemotherapy [methods]; 7. Mesalamine [*administration & dosage, adverse effects]; 8. Patient Dropouts [statistics & numerical data]; 9. Placebos [therapeutic use]; 10. Randomized Controlled Trials as Topic; 11. Remission Induction; 12. Sulfasalazine [*administration & dosage, adverse effects]; 13. Treatment Failure; | Provide MESH terms for the study
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Abdominal Pain [epidemiology]; 2. Age Factors; 3. Capsules [administration & dosage]; 4. Cystic Fibrosis [*therapy]; 5. Delayed-Action Preparations; 6. Enzyme Replacement Therapy [adverse effects, *standards]; 7. Gastrointestinal Agents [therapeutic use]; 8. Microspheres; 9. Nutritional Status; 10. Pancreas [enzymology]; 11. Randomized Controlled Trials as Topic; 12. Weight Gain; | Provide MESH terms for the study
Pancreatic enzyme replacement therapy for people with cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [*therapeutic use]; 2. *Antibiotic Prophylaxis; 3. Bias; 4. Graft Survival; 5. Pneumonia [epidemiology]; 6. Randomized Controlled Trials as Topic; 7. Sepsis [epidemiology]; 8. Surgical Wound Infection [mortality, *prevention & control]; 9. *Transplant Recipients; | Provide MESH terms for the study
Perioperative antibiotics for preventing post‐surgical site infections in solid organ transplant recipients | You are a research assistant. Based on the question please provide appropriate answers |
1. Adamantane [adverse effects, analogs & derivatives, therapeutic use]; 2. Bias; 3. Cause of Death; 4. Diabetes Mellitus, Type 1 [blood, *drug therapy]; 5. Diabetes Mellitus, Type 2 [blood, *drug therapy]; 6. Dipeptidyl-Peptidase IV Inhibitors [adverse effects, *therapeutic use]; 7. Fasting [blood]; 8. Glycated Hemoglobin [metabolism]; 9. Graft Survival [drug effects]; 10. Hypoglycemia [chemically induced]; 11. Hypoglycemic Agents [adverse effects, *therapeutic use]; 12. Insulin [adverse effects, therapeutic use]; 13. Insulin Glargine [adverse effects, therapeutic use]; 14. Kidney Transplantation [*adverse effects]; 15. Nitriles [adverse effects, therapeutic use]; 16. Pioglitazone; 17. Postoperative Complications [*drug therapy, etiology]; 18. Pyrrolidines [adverse effects, therapeutic use]; 19. Randomized Controlled Trials as Topic; 20. Sitagliptin Phosphate [adverse effects, therapeutic use]; 21. Sodium-Glucose Transporter 2 Inhibitors [adverse effects, therapeutic use]; 22. Thiazolidinediones [adverse effects, therapeutic use]; 23. Transplant Recipients; 24. Vildagliptin; | Provide MESH terms for the study
Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients | You are a research assistant. Based on the question please provide appropriate answers |
1. Birth Weight; 2. Enterocolitis, Necrotizing [epidemiology]; 3. *Food, Fortified; 4. Head [growth & development]; 5. Infant, Premature [*growth & development]; 6. Infant, Very Low Birth Weight [*growth & development]; 7. *Milk, Human; 8. Randomized Controlled Trials as Topic; 9. Time Factors; | Provide MESH terms for the study
Early fortification of human milk versus late fortification to promote growth in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Anti-Infective Agents [administration & dosage, *therapeutic use]; 3. Bias; 4. Burns [*therapy]; 5. Carboxymethylcellulose Sodium [administration & dosage, therapeutic use]; 6. Facial Injuries [*therapy]; 7. Randomized Controlled Trials as Topic; 8. *Skin, Artificial; 9. Wound Healing [drug effects]; | Provide MESH terms for the study
Topical treatment for facial burns | You are a research assistant. Based on the question please provide appropriate answers |
1. Anemia, Iron-Deficiency [epidemiology]; 2. Bias; 3. Body Height; 4. Body Weight; 5. Child Development; 6. Developed Countries; 7. Developing Countries; 8. *Family; 9. Infant Death; 10. Infant Food; 11. Infant Nutrition Disorders [prevention & control]; 12. *Infant Nutritional Physiological Phenomena; 13. Prevalence; 14. Randomized Controlled Trials as Topic; 15. Term Birth; 16. *Weaning; | Provide MESH terms for the study
Education of family members to support weaning to solids and nutrition in later infancy in term‐born infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta-Antagonists [*therapeutic use]; 2. Carbazoles [therapeutic use]; 3. Carvedilol; 4. Heart Failure [*drug therapy, mortality]; 5. Heart Transplantation [statistics & numerical data]; 6. Metoprolol [therapeutic use]; 7. Propanolamines [therapeutic use]; 8. Propranolol [therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Stroke Volume; | Provide MESH terms for the study
Beta‐blockers for congestive heart failure in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Actigraphy [*instrumentation]; 2. Bias; 3. Cardiovascular Diseases [etiology]; 4. Health Promotion [*methods]; 5. Motor Activity [*physiology]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Risk Factors; 9. Sedentary Behavior; 10. Walking [*physiology]; 11. *Workplace; | Provide MESH terms for the study
Workplace pedometer interventions for increasing physical activity | You are a research assistant. Based on the question please provide appropriate answers |
1. Bipolar Disorder [*complications]; 2. Obesity [complications, *therapy]; | Provide MESH terms for the study
Interventions for the management of obesity in people with bipolar disorder | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [*administration & dosage]; 2. Antibodies, Monoclonal [therapeutic use]; 3. Bacterial Infections [*drug therapy, microbiology]; 4. beta Carotene [therapeutic use]; 5. Chemotherapy, Adjuvant; 6. Cystic Fibrosis [*complications]; 7. Disease Progression; 8. Garlic; 9. Immunoglobulin Fab Fragments [therapeutic use]; 10. Lung Diseases [*drug therapy, microbiology]; 11. Nitric Oxide [therapeutic use]; 12. Pseudomonas aeruginosa; 13. Pseudomonas Infections [drug therapy]; 14. Randomized Controlled Trials as Topic; 15. Vitamins [therapeutic use]; 16. Zinc [administration & dosage]; | Provide MESH terms for the study
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Asthmatic Agents [*therapeutic use]; 2. Asthma [*drug therapy]; 3. Atorvastatin [*therapeutic use]; 4. Forced Expiratory Volume [drug effects]; 5. Hydroxymethylglutaryl-CoA Reductase Inhibitors [*therapeutic use]; 6. Peak Expiratory Flow Rate [drug effects]; | Provide MESH terms for the study
Statins for asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Beds; 2. Cerebral Intraventricular Hemorrhage [epidemiology, etiology, *prevention & control]; 3. Cerebrovascular Circulation [physiology]; 4. *Head; 5. Infant Mortality; 6. Infant, Premature; 7. Infant, Premature, Diseases [epidemiology, etiology, *prevention & control]; 8. Patient Positioning [*methods]; 9. Publication Bias; 10. Randomized Controlled Trials as Topic; 11. Retinopathy of Prematurity [epidemiology]; 12. Rotation; 13. *Supine Position; | Provide MESH terms for the study
Head midline position for preventing the occurrence or extension of germinal matrix‐intraventricular haemorrhage in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Cognition [physiology]; 3. *Cognitive Remediation; 4. Combined Modality Therapy [methods]; 5. *Family Therapy; 6. Memory, Short-Term; 7. Patient Dropouts [statistics & numerical data]; 8. *Psychotherapy, Group; 9. Psychotic Disorders [*therapy]; 10. Schizophrenia [*therapy]; 11. Therapy, Computer-Assisted; 12. Treatment Outcome; 13. Video Games; | Provide MESH terms for the study
Psychological interventions for psychosis in adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [adverse effects, *therapeutic use]; 2. Chemotherapy, Adjuvant [methods]; 3. Dizziness [chemically induced]; 4. Drug Eruptions [etiology]; 5. Drug Resistant Epilepsy [*drug therapy]; 6. Epilepsy, Tonic-Clonic [*drug therapy]; 7. Exanthema [chemically induced]; 8. Fatigue [chemically induced]; 9. Lamotrigine [adverse effects, *therapeutic use]; 10. Nausea [chemically induced]; 11. Patient Dropouts [statistics & numerical data]; 12. Randomized Controlled Trials as Topic; 13. Sleepiness; | Provide MESH terms for the study
Lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures | You are a research assistant. Based on the question please provide appropriate answers |
1. *Aluminum; 2. *Bedding and Linens; 3. Bias; 4. Bilirubin [blood]; 5. Hyperbilirubinemia, Neonatal [*therapy]; 6. Infant, Premature; 7. Jaundice, Neonatal [therapy]; 8. Lighting [instrumentation]; 9. Phototherapy [instrumentation, *methods]; 10. *Plastics; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia | You are a research assistant. Based on the question please provide appropriate answers |
1. Cause of Death; 2. Chelating Agents [adverse effects, *therapeutic use]; 3. Chelation Therapy [adverse effects, *methods]; 4. Chronic Disease; 5. Hyperkalemia [*drug therapy, etiology, mortality]; 6. Polymers [adverse effects, therapeutic use]; 7. Polystyrenes [adverse effects, therapeutic use]; 8. *Potassium; 9. Quality of Life; 10. Randomized Controlled Trials as Topic; 11. Renal Insufficiency, Chronic [*complications]; 12. Silicates [adverse effects, therapeutic use]; | Provide MESH terms for the study
Potassium binders for chronic hyperkalaemia in people with chronic kidney disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Age Factors; 2. Diet, Carbohydrate-Restricted [methods]; 3. Diet, High-Protein Low-Carbohydrate [methods]; 4. Diet, Ketogenic [adverse effects, *methods]; 5. Dietary Carbohydrates [*administration & dosage]; 6. Dietary Fats [*administration & dosage]; 7. Drug Resistant Epilepsy [*diet therapy]; 8. Intention to Treat Analysis; 9. Prospective Studies; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; 12. Retrospective Studies; 13. Sample Size; | Provide MESH terms for the study
Ketogenic diets for drug‐resistant epilepsy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Adaptation, Psychological; 2. Attitude; 3. Cognition Disorders [psychology]; 4. Cognitive Behavioral Therapy [*methods]; 5. Desensitization, Psychologic; 6. Fantasy; 7. Randomized Controlled Trials as Topic; 8. Rape [psychology]; 9. Recidivism; 10. Self Concept; 11. Sex Education; 12. Sex Offenses [*prevention & control, psychology]; 13. Social Skills; | Provide MESH terms for the study
Cognitive‐behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour | You are a research assistant. Based on the question please provide appropriate answers |
1. Atorvastatin [administration & dosage]; 2. Cardiovascular Diseases [blood, prevention & control]; 3. Cholesterol, HDL [blood]; 4. Cholesterol, LDL [blood]; 5. Controlled Before-After Studies; 6. Drug Administration Schedule; 7. Fluvastatin [administration & dosage]; 8. Hydroxymethylglutaryl-CoA Reductase Inhibitors [*administration & dosage]; 9. Lipids [*blood]; 10. Pyridines [administration & dosage]; 11. Quinolines [*administration & dosage]; 12. Randomized Controlled Trials as Topic; 13. Rosuvastatin Calcium [administration & dosage]; 14. Sex Factors; 15. Triglycerides [blood]; | Provide MESH terms for the study
Pitavastatin for lowering lipids | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [administration & dosage, adverse effects, *therapeutic use]; 2. Catheter Obstruction [statistics & numerical data]; 3. Catheterization, Central Venous [*adverse effects]; 4. Hemorrhage [chemically induced]; 5. Heparin [administration & dosage]; 6. Heparin, Low-Molecular-Weight [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Thrombosis [etiology, *prevention & control]; | Provide MESH terms for the study
Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Equipment Design; 2. Hydrocephalus [complications, mortality, *surgery]; 3. Microcomputers; 4. Randomized Controlled Trials as Topic; 5. Treatment Failure; 6. Uncertainty; 7. Ventriculoperitoneal Shunt [adverse effects, *instrumentation, mortality]; | Provide MESH terms for the study
Ventriculo‐peritoneal shunting devices for hydrocephalus | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [*therapeutic use]; 2. Biofilms [*drug effects, growth & development]; 3. Cystic Fibrosis [*complications]; 4. Microbial Sensitivity Tests [methods]; 5. Pseudomonas aeruginosa [*drug effects, physiology]; 6. Pseudomonas Infections [complications, *drug therapy]; 7. Randomized Controlled Trials as Topic; 8. Respiratory Tract Infections [*drug therapy, microbiology]; 9. Sputum [microbiology]; | Provide MESH terms for the study
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [*therapeutic use]; 2. Cystic Fibrosis [*microbiology]; 3. Drug Therapy, Combination [methods]; 4. Lung Diseases [*drug therapy, microbiology]; 5. Mycobacterium abscessus; 6. Mycobacterium avium Complex; 7. Mycobacterium Infections, Nontuberculous [*drug therapy]; 8. Nontuberculous Mycobacteria; | Provide MESH terms for the study
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Biomarkers [blood]; 2. Blood Coagulation [drug effects]; 3. Bone Density; 4. Cystic Fibrosis [*blood, complications]; 5. Dietary Supplements; 6. Fractures, Bone [prevention & control]; 7. Osteocalcin [blood]; 8. Osteogenesis [*drug effects]; 9. Protein Precursors [blood]; 10. Prothrombin; 11. Quality of Life; 12. Randomized Controlled Trials as Topic; 13. Vitamin K [*administration & dosage, blood]; 14. Vitamin K Deficiency [complications, *drug therapy]; 15. Vitamins [*administration & dosage]; | Provide MESH terms for the study
Vitamin K supplementation for cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Food, Fortified; 2. *Infant Nutritional Physiological Phenomena; 3. Infant, Premature [*growth & development]; 4. Milk, Human [*chemistry]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Multi‐nutrient fortification of human milk for preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Adipose Tissue; 2. *Adiposity; 3. Blood Pressure; 4. Body Mass Index; 5. Body Weight; 6. Cholesterol [blood]; 7. Cholesterol, HDL [blood]; 8. Cholesterol, LDL [blood]; 9. Diet, Fat-Restricted; 10. Diet, High-Protein; 11. Dietary Fats [*administration & dosage]; 12. *Energy Intake; 13. Quality of Life; 14. Randomized Controlled Trials as Topic; 15. Triglycerides [blood]; 16. Waist Circumference; | Provide MESH terms for the study
Effects of total fat intake on body fatness in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Body Weight [drug effects]; 3. Breast Feeding; 4. Domperidone [administration & dosage, adverse effects]; 5. Galactogogues [*administration & dosage, adverse effects]; 6. Lactation [*drug effects]; 7. Metoclopramide [administration & dosage, adverse effects]; 8. *Milk, Human [drug effects]; 9. Mothers; 10. Phytotherapy [adverse effects, *methods]; 11. Plant Extracts [*administration & dosage, adverse effects]; 12. Randomized Controlled Trials as Topic; 13. Sulpiride [administration & dosage, adverse effects]; 14. Thyrotropin-Releasing Hormone [administration & dosage, adverse effects]; | Provide MESH terms for the study
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Botulinum Toxins, Type A [therapeutic use]; 2. Casts, Surgical; 3. Clubfoot [*therapy]; 4. Decompression, Surgical [methods]; 5. Ligaments, Articular [surgery]; 6. Motion Therapy, Continuous Passive [methods]; 7. Neuromuscular Agents [therapeutic use]; 8. Orthopedic Procedures [methods]; 9. Randomized Controlled Trials as Topic; 10. Recurrence; 11. Treatment Outcome; | Provide MESH terms for the study
Interventions for congenital talipes equinovarus (clubfoot) | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [*therapeutic use]; 2. Chronic Disease; 3. Cystic Fibrosis [*microbiology]; 4. Disease Progression; 5. Drug Therapy, Combination; 6. Microbial Sensitivity Tests; 7. *Pseudomonas aeruginosa [drug effects]; 8. Pseudomonas Infections [*drug therapy]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Artificial Organs; 2. *Cornea; 3. *Corneal Transplantation; 4. Reoperation; | Provide MESH terms for the study
Artificial corneas versus donor corneas for repeat corneal transplants | You are a research assistant. Based on the question please provide appropriate answers |
1. Absorbent Pads; 2. Case-Control Studies; 3. *Clinical Alarms; 4. Combined Modality Therapy [methods]; 5. Deamino Arginine Vasopressin [therapeutic use]; 6. Nephrology [methods]; 7. Nocturnal Enuresis [drug therapy, *prevention & control]; 8. Placebos [therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Renal Agents [therapeutic use]; 11. Treatment Outcome; | Provide MESH terms for the study
Alarm interventions for nocturnal enuresis in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Acne Vulgaris [*drug therapy]; 2. Adapalene [adverse effects, therapeutic use]; 3. Anti-Bacterial Agents [therapeutic use]; 4. Benzoyl Peroxide [therapeutic use]; 5. Bias; 6. Clindamycin [adverse effects, therapeutic use]; 7. Dermatologic Agents [adverse effects, *therapeutic use]; 8. Dicarboxylic Acids [adverse effects, therapeutic use]; 9. Erythromycin [adverse effects, therapeutic use]; 10. Glycolates [therapeutic use]; 11. Keratolytic Agents [therapeutic use]; 12. Mandelic Acids [therapeutic use]; 13. Niacinamide [adverse effects, therapeutic use]; 14. Patient Dropouts [statistics & numerical data]; 15. Pyruvic Acid [adverse effects, therapeutic use]; 16. Quality of Life; 17. Salicylic Acid [therapeutic use]; 18. Sulfur [therapeutic use]; 19. Tretinoin [therapeutic use]; 20. Zinc [therapeutic use]; | Provide MESH terms for the study
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [*administration & dosage]; 2. Anti-Bacterial Agents [*administration & dosage]; 3. Drug Therapy, Combination [methods]; 4. Pharyngitis [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Time Factors; 7. Tonsillitis [drug therapy]; 8. Treatment Outcome; | Provide MESH terms for the study
Corticosteroids as standalone or add‐on treatment for sore throat | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Cystic Fibrosis [*drug therapy, physiopathology]; 3. Deoxyribonuclease I [*administration & dosage]; 4. Forced Expiratory Volume; 5. Mannitol [*administration & dosage, adverse effects]; 6. Mucociliary Clearance; 7. Powders; 8. Randomized Controlled Trials as Topic; 9. Recombinant Proteins [administration & dosage]; 10. Respiratory Function Tests; 11. Vital Capacity; | Provide MESH terms for the study
Inhaled mannitol for cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Catheter Obstruction [statistics & numerical data]; 2. Catheter-Related Infections [epidemiology, prevention & control]; 3. *Central Venous Catheters [adverse effects, statistics & numerical data]; 4. Fibrinolytic Agents [*administration & dosage]; 5. Heparin [*administration & dosage]; 6. Randomized Controlled Trials as Topic; 7. Sodium Chloride [*administration & dosage]; | Provide MESH terms for the study
Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children | You are a research assistant. Based on the question please provide appropriate answers |
1. Breathing Exercises; 2. Chest Wall Oscillation [*instrumentation]; 3. Cystic Fibrosis [*complications, physiopathology]; 4. Disease Progression; 5. Forced Expiratory Flow Rates; 6. Forced Expiratory Volume; 7. Lung Diseases, Obstructive [etiology, *therapy]; 8. *Mucociliary Clearance; 9. Mucus [*metabolism]; 10. Patient Satisfaction; 11. Randomized Controlled Trials as Topic; 12. Sputum [metabolism]; 13. Vibration [*therapeutic use]; | Provide MESH terms for the study
Oscillating devices for airway clearance in people with cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Loss, Surgical [statistics & numerical data]; 2. Pain, Postoperative [epidemiology]; 3. Palatine Tonsil [*surgery]; 4. Postoperative Complications [epidemiology]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Reoperation [statistics & numerical data]; 9. Severity of Illness Index; 10. Sleep Apnea, Obstructive [*surgery]; 11. Tonsillectomy [adverse effects, *methods]; | Provide MESH terms for the study
Tonsillectomy versus tonsillotomy for obstructive sleep‐disordered breathing in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Amphotericin B [adverse effects, *therapeutic use]; 2. Anti-HIV Agents [therapeutic use]; 3. Antifungal Agents [adverse effects, *therapeutic use]; 4. Cohort Studies; 5. Deoxycholic Acid; 6. Drug Administration Schedule; 7. Fluconazole [therapeutic use]; 8. Histoplasmosis [*drug therapy, mortality]; 9. HIV Infections [*complications, drug therapy]; 10. Induction Chemotherapy; 11. Itraconazole [therapeutic use]; 12. Kidney [drug effects]; 13. Liposomes; 14. Maintenance Chemotherapy; 15. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Treating progressive disseminated histoplasmosis in people living with HIV | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [administration & dosage, *therapeutic use]; 2. Clonazepam [administration & dosage, *therapeutic use]; 3. Drug Resistant Epilepsy [*drug therapy]; | Provide MESH terms for the study
Clonazepam add‐on therapy for drug‐resistant epilepsy | You are a research assistant. Based on the question please provide appropriate answers |
1. Calcium [*therapeutic use]; 2. Fractures, Bone [epidemiology, prevention & control]; 3. Randomized Controlled Trials as Topic; 4. Rickets [etiology, *therapy]; 5. Vitamin D [*therapeutic use]; 6. Vitamin D Deficiency [complications, therapy]; 7. Vitamins [*therapeutic use]; | Provide MESH terms for the study
Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Continuous Positive Airway Pressure [adverse effects, statistics & numerical data]; 2. High‐Frequency Ventilation [adverse effects, statistics & numerical data]; 3. Oxygen Inhalation Therapy [adverse effects, statistics & numerical data]; 4. Pneumothorax [etiology]; 5. Randomized Controlled Trials as Topic; 6. Respiration, Artificial [statistics & numerical data]; 7. Respiratory Therapy [adverse effects, *methods]; 8. Time Factors; 9. Transient Tachypnea of the Newborn [mortality, *therapy]; | Provide MESH terms for the study
Non‐invasive respiratory support for the management of transient tachypnea of the newborn | You are a research assistant. Based on the question please provide appropriate answers |
1. Adalimumab [administration & dosage, adverse effects]; 2. Anti‐Inflammatory Agents [administration & dosage, adverse effects]; 3. Cognitive Behavioral Therapy; 4. Electroacupuncture; 5. Exercise; 6. Fatigue [etiology, *therapy]; 7. Fatty Acids, Omega‐3 [administration & dosage, adverse effects]; 8. Ferric Compounds [adverse effects]; 9. Hematinics [adverse effects]; 10. Inflammatory Bowel Diseases [*complications]; 11. Psychotherapy, Brief; 12. Pyrones [adverse effects]; 13. Quality of Life; 14. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for fatigue in inflammatory bowel disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Albendazole [administration & dosage, therapeutic use]; 2. Anthelmintics [administration & dosage, *therapeutic use]; 3. Ascariasis [*drug therapy]; 4. Ascaris lumbricoides; 5. Ivermectin [administration & dosage, therapeutic use]; 6. Mebendazole [administration & dosage, therapeutic use]; 7. Parasite Egg Count; 8. Placebos [therapeutic use]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Anthelmintic drugs for treating ascariasis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Dietary Supplements; 2. Bias; 3. Cystic Fibrosis [blood, *diet therapy]; 4. Disease Progression; 5. Fatty Acids, Omega‐3 [*administration & dosage, adverse effects]; 6. Fatty Acids, Omega‐6 [administration & dosage]; 7. Forced Expiratory Volume; 8. Olive Oil [administration & dosage]; 9. Randomized Controlled Trials as Topic; 10. Vital Capacity; | Provide MESH terms for the study
Omega‐3 fatty acid supplementation for cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Absenteeism; 2. Gastrointestinal Diseases [epidemiology, prevention & control]; 3. Hand Hygiene [*methods]; 4. Preventive Medicine [methods]; 5. Randomized Controlled Trials as Topic; 6. Respiratory Tract Diseases [epidemiology, prevention & control]; 7. Schools [statistics & numerical data]; | Provide MESH terms for the study
Rinse‐free hand wash for reducing absenteeism among preschool and school children | You are a research assistant. Based on the question please provide appropriate answers |
1. Aflatoxins [*poisoning]; 2. Agriculture [*education, methods]; 3. Breast Feeding; 4. *Developing Countries; 5. Food Contamination [*prevention & control]; 6. *Growth; 7. Kenya; 8. Prenatal Exposure Delayed Effects [prevention & control]; 9. Randomized Controlled Trials as Topic; 10. Tanzania; 11. Thinness [prevention & control]; 12. Zimbabwe; | Provide MESH terms for the study
Agricultural and nutritional education interventions for reducing aflatoxin exposure to improve infant and child growth in low‐ and middle‐income countries | You are a research assistant. Based on the question please provide appropriate answers |
1. *Electroencephalography; 2. *Seizures, Febrile; 3. Time Factors; | Provide MESH terms for the study
EEG for children with complex febrile seizures | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics [*therapeutic use]; 2. Clonidine [*therapeutic use]; 3. Pain, Postoperative [*prevention & control]; 4. Pain, Procedural [*drug therapy, prevention & control]; | Provide MESH terms for the study
Clonidine for pain in non‐ventilated infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Amino Acids [administration & dosage, adverse effects]; 2. Bias; 3. Critical Illness [*therapy]; 4. Cross Infection [epidemiology]; 5. Fat Emulsions, Intravenous [administration & dosage, adverse effects]; 6. Hospital Mortality; 7. Hypoglycemia [epidemiology]; 8. Infant Mortality; 9. Infant, Premature; 10. Length of Stay; 11. Lipids [administration & dosage, adverse effects]; 12. Parenteral Nutrition [adverse effects, mortality, *statistics & numerical data]; 13. Parenteral Nutrition Solutions [administration & dosage, adverse effects]; 14. Randomized Controlled Trials as Topic; 15. Respiration, Artificial [statistics & numerical data]; 16. Term Birth; 17. Time Factors; | Provide MESH terms for the study
Early versus late parenteral nutrition for critically ill term and late preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise; 2. Acute Disease; 3. Bicycling; 4. Randomized Controlled Trials as Topic; 5. Respiratory Tract Infections [epidemiology, *prevention & control]; 6. Severity of Illness Index; 7. Time Factors; 8. Walking; | Provide MESH terms for the study
Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections | You are a research assistant. Based on the question please provide appropriate answers |
1. *Burkholderia cepacia complex; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Burkholderia Infections [*drug therapy, microbiology]; 4. Cystic Fibrosis [*complications]; 5. Disease Progression; | Provide MESH terms for the study
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation | You are a research assistant. Based on the question please provide appropriate answers |
1. *Patient Safety; 2. Case‐Control Studies; 3. Cohort Studies; 4. Death, Sudden [etiology, *prevention & control]; 5. Epilepsy [*complications]; 6. Epilepsy, Tonic‐Clonic [complications, prevention & control]; 7. Monitoring, Physiologic [methods]; 8. Quality of Life; 9. Sleep; | Provide MESH terms for the study
Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP) | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Bacterial Infections [epidemiology, prevention & control]; 3. Cause of Death; 4. Chronic Disease; 5. *Enteral Nutrition; 6. Enterocolitis, Necrotizing [epidemiology, *prevention & control]; 7. Infant, Premature; 8. Infant, Premature, Diseases [*prevention & control]; 9. Lacticaseibacillus rhamnosus; 10. Lactoferrin [*administration & dosage]; 11. Lung Diseases [epidemiology]; 12. Mycoses [epidemiology, prevention & control]; 13. Numbers Needed To Treat; 14. Probiotics [*administration & dosage]; 15. Randomized Controlled Trials as Topic; 16. Retinopathy of Prematurity [epidemiology]; 17. Sepsis [*prevention & control]; | Provide MESH terms for the study
Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Cystic Fibrosis [*complications, genetics]; 2. Cystic Fibrosis Transmembrane Conductance Regulator [genetics]; 3. Gastrointestinal Hemorrhage [prevention & control]; 4. Hypertension, Portal [prevention & control]; 5. Liver Diseases [etiology, prevention & control, *therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for preventing and managing advanced liver disease in cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Pain Management; 2. *Physical Therapy Modalities; 3. *Quality of Life; 4. Cystic Fibrosis [*physiopathology]; 5. Posture; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Physical therapies for postural abnormalities in people with cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Hyperplasia, Congenital [*drug therapy]; 2. Dexamethasone; 3. Glucocorticoids [*therapeutic use]; 4. Prednisolone; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia | You are a research assistant. Based on the question please provide appropriate answers |
1. Cerebral Intraventricular Hemorrhage [epidemiology]; 2. Ductus Arteriosus, Patent [drug therapy, epidemiology]; 3. Heart Massage; 4. Hospital Mortality; 5. Intubation, Intratracheal [methods, mortality]; 6. Lung Diseases [epidemiology]; 7. Pneumothorax [epidemiology]; 8. Positive‐Pressure Respiration [instrumentation, *methods, mortality]; 9. Pulmonary Surfactants [administration & dosage]; 10. Randomized Controlled Trials as Topic; 11. Respiration, Artificial [statistics & numerical data]; 12. Resuscitation [*methods]; 13. Time Factors; | Provide MESH terms for the study
Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes | You are a research assistant. Based on the question please provide appropriate answers |
1. Continuous Positive Airway Pressure; 2. Diaphragm [*physiology]; 3. *Infant, Premature; 4. Interactive Ventilatory Support; 5. Intermittent Positive-Pressure Ventilation; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Diaphragm‐triggered non‐invasive respiratory support in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [*therapeutic use]; 2. Budesonide [therapeutic use]; 3. Cesarean Section; 4. Infant, Premature; 5. Oxygen Inhalation Therapy; 6. Randomized Controlled Trials as Topic; 7. Respiration, Artificial; 8. Transient Tachypnea of the Newborn [*drug therapy]; | Provide MESH terms for the study
Postnatal corticosteroids for transient tachypnoea of the newborn | You are a research assistant. Based on the question please provide appropriate answers |
1. Calcineurin Inhibitors [adverse effects, therapeutic use]; 2. Cause of Death; 3. Confidence Intervals; 4. Creatinine [blood]; 5. Drug Administration Schedule; 6. Drug Therapy, Combination; 7. Glomerular Filtration Rate [drug effects]; 8. Glomerulonephritis, IGA [*drug therapy]; 9. Immunosuppressive Agents [adverse effects, *therapeutic use]; 10. Kidney Failure, Chronic [mortality, prevention & control, therapy]; 11. Leflunomide [adverse effects, therapeutic use]; 12. Mycophenolic Acid [adverse effects, therapeutic use]; 13. Proteinuria [drug therapy]; 14. Randomized Controlled Trials as Topic; 15. Remission Induction; 16. Ribonucleosides [adverse effects, therapeutic use]; 17. Risk; 18. Steroids [administration & dosage, adverse effects, *therapeutic use]; | Provide MESH terms for the study
Immunosuppressive agents for treating IgA nephropathy | You are a research assistant. Based on the question please provide appropriate answers |
1. End Stage Liver Disease [*complications]; 2. Esophageal and Gastric Varices [complications]; 3. Gastrointestinal Hemorrhage [*prevention & control]; 4. Hypertension, Portal [*complications]; 5. Ligation [methods]; 6. Portal Vein; 7. Primary Prevention; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Sclerotherapy [*methods]; 11. Venous Thrombosis [*complications]; | Provide MESH terms for the study
Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Inflammatory Agents, Non-Steroidal [therapeutic use]; 2. Colitis, Ulcerative [*therapy]; 3. Mesalamine [therapeutic use]; 4. Probiotics [adverse effects, *therapeutic use]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Remission Induction; | Provide MESH terms for the study
Probiotics for maintenance of remission in ulcerative colitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Avitaminosis [prevention & control]; 2. Deficiency Diseases; 3. Dietary Supplements; 4. *Food, Fortified; 5. Infant Nutritional Physiological Phenomena [*physiology]; 6. Micronutrients [*administration & dosage, deficiency]; 7. Nutritional Status; 8. Randomized Controlled Trials as Topic; 9. Trace Elements [administration & dosage]; 10. Vitamins [*administration & dosage]; | Provide MESH terms for the study
Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age | You are a research assistant. Based on the question please provide appropriate answers |
1. *Mucociliary Clearance; 2. Administration, Inhalation; 3. Cystic Fibrosis [*drug therapy]; 4. Drug Administration Schedule; 5. Saline Solution, Hypertonic [administration & dosage, *therapeutic use]; 6. Sputum [metabolism]; | Provide MESH terms for the study
Timing of hypertonic saline inhalation for cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [*administration & dosage]; 2. Cardiac Catheterization [*adverse effects]; 3. Hemorrhage [chemically induced]; 4. Heparin [*administration & dosage]; 5. Infusions, Intravenous [methods]; 6. Peripheral Arterial Disease [*prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Thrombosis [*prevention & control]; | Provide MESH terms for the study
Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Low Birth Weight; 2. Cyclooxygenase Inhibitors [therapeutic use]; 3. Ductus Arteriosus, Patent [*drug therapy]; 4. Enzyme Inhibitors [adverse effects, therapeutic use]; 5. Ibuprofen [adverse effects, *therapeutic use]; 6. Indomethacin [adverse effects, therapeutic use]; 7. Infant, Premature; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Anemia, Neonatal [blood, prevention & control]; 2. Epoetin Alfa; 3. Erythrocyte Transfusion [*statistics & numerical data]; 4. Erythropoietin [*administration & dosage, adverse effects, blood]; 5. Infant, Low Birth Weight [*blood]; 6. Infant, Premature [*blood]; 7. Randomized Controlled Trials as Topic; 8. Retinopathy of Prematurity [blood, prevention & control]; | Provide MESH terms for the study
Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Premature; 2. Hemorrhage [*drug therapy]; 3. Lung Diseases [*drug therapy]; 4. Pulmonary Surfactants [*therapeutic use]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Surfactant for pulmonary haemorrhage in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. Cross Infection [*prevention & control]; 2. IgG Deficiency [drug therapy]; 3. Immunoglobulin G [*administration & dosage, therapeutic use]; 4. Immunoglobulins, Intravenous [therapeutic use]; 5. Infant, Low Birth Weight [immunology]; 6. Infant, Premature [immunology]; 7. Infant, Premature, Diseases [*prevention & control]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetaminophen [*therapeutic use]; 2. Analgesics, Non‐Narcotic [*therapeutic use]; 3. Pain [*drug therapy, prevention & control]; 4. Pain Management; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Paracetamol (acetaminophen) for prevention or treatment of pain in newborns | You are a research assistant. Based on the question please provide appropriate answers |
1. Colitis, Ulcerative [*drug therapy]; 2. Janus Kinase Inhibitors [*therapeutic use]; 3. Maintenance Chemotherapy; 4. Piperidines [*therapeutic use]; 5. Protein Kinase Inhibitors; 6. Pyrimidines [*therapeutic use]; 7. Pyrroles [*therapeutic use]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Aging [pathology]; 2. Emollients [*therapeutic use]; 3. Phototherapy; 4. Pruritus [drug therapy, etiology, *therapy]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Severity of Illness Index; 8. Skin Care [*methods]; 9. Skin Cream [*therapeutic use]; 10. Treatment Outcome; | Provide MESH terms for the study
Interventions for chronic pruritus of unknown origin | You are a research assistant. Based on the question please provide appropriate answers |
1. Cystic Fibrosis [complications, *microbiology, *therapy]; 2. Leukocyte L1 Antigen Complex [*analysis]; 3. Probiotics [*therapeutic use]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Treatment Outcome; | Provide MESH terms for the study
Probiotics for people with cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Controlled Before‐After Studies; 2. Health Education [*methods]; 3. Health Personnel [education]; 4. Parents [education]; 5. Randomized Controlled Trials as Topic; 6. Vaccination [*statistics & numerical data, trends]; | Provide MESH terms for the study
Improving vaccination uptake among adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Brain Injuries [*complications]; 2. Brain Injuries, Traumatic [*complications]; 3. Glasgow Outcome Scale; 4. Intracranial Hypertension [*drug therapy]; 5. Intracranial Pressure [*drug effects]; 6. Randomized Controlled Trials as Topic; 7. Saline Solution, Hypertonic [*therapeutic use]; | Provide MESH terms for the study
Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetates; 2. Adenoidectomy; 3. Anti‐Inflammatory Agents [*therapeutic use]; 4. Cyclopropanes; 5. Quinolines; 6. Randomized Controlled Trials as Topic; 7. Sleep Apnea, Obstructive [*drug therapy]; 8. Sulfides; 9. Tonsillectomy; | Provide MESH terms for the study
Anti‐inflammatory medications for obstructive sleep apnoea in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta-Antagonists [therapeutic use]; 2. Esophageal and Gastric Varices [*therapy]; 3. Gastrointestinal Hemorrhage [*prevention & control]; 4. Ligation; 5. Liver Cirrhosis [complications]; 6. Portal Vein; 7. Primary Prevention; 8. Randomized Controlled Trials as Topic; 9. *Sclerotherapy; 10. Venous Thrombosis [complications]; | Provide MESH terms for the study
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Anti‐Infective Agents, Local [administration & dosage, *therapeutic use]; 3. Chronic Disease; 4. Otitis Media, Suppurative [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Treatment Outcome; | Provide MESH terms for the study
Topical antiseptics for chronic suppurative otitis media | You are a research assistant. Based on the question please provide appropriate answers |
1. Amines [therapeutic use]; 2. Creatine [therapeutic use]; 3. Cyclohexanecarboxylic Acids [therapeutic use]; 4. gamma-Aminobutyric Acid [therapeutic use]; 5. Hydroxyurea [therapeutic use]; 6. Neuroprotective Agents [*therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Spinal Muscular Atrophies of Childhood [*drug therapy]; 9. Thyrotropin-Releasing Hormone [therapeutic use]; | Provide MESH terms for the study
Drug treatment for spinal muscular atrophy types II and III | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Anti-Bacterial Agents [*therapeutic use]; 3. Anti-Infective Agents, Local [*therapeutic use]; 4. Otitis Media, Suppurative [*drug therapy]; 5. Quinolones [therapeutic use]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotics versus topical antiseptics for chronic suppurative otitis media | You are a research assistant. Based on the question please provide appropriate answers |
1. Caregivers; 2. Child Nutritional Physiological Phenomena [*physiology]; 3. *Diet; 4. Eating; 5. Energy Intake; 6. Exercise [*physiology]; 7. Fruit; 8. *Health Behavior; 9. *Parents; 10. Pediatric Obesity [prevention & control]; 11. Randomized Controlled Trials as Topic; 12. Vegetables; | Provide MESH terms for the study
Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Anti‐Bacterial Agents [administration & dosage, *therapeutic use]; 3. Chronic Disease; 4. Otitis Media, Suppurative [complications, *drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Treatment Outcome; | Provide MESH terms for the study
Topical antibiotics for chronic suppurative otitis media | You are a research assistant. Based on the question please provide appropriate answers |
1. Brain Injuries, Traumatic [*complications]; 2. Decompressive Craniectomy [*methods]; 3. Intracranial Hypertension [*surgery]; 4. Intracranial Pressure; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury | You are a research assistant. Based on the question please provide appropriate answers |
1. Adenoidectomy [methods]; 2. Fever [surgery]; 3. Lymphadenitis [*surgery]; 4. Periodicity; 5. Pharyngitis [*surgery]; 6. Randomized Controlled Trials as Topic; 7. Stomatitis, Aphthous [*surgery]; 8. Syndrome; 9. Tonsillectomy [*methods]; | Provide MESH terms for the study
Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA) | You are a research assistant. Based on the question please provide appropriate answers |
1. Diarrhea [*drug therapy]; 2. Fluid Therapy; 3. Length of Stay; 4. Randomized Controlled Trials as Topic; 5. Thiorphan [*analogs & derivatives, therapeutic use]; 6. Treatment Outcome; | Provide MESH terms for the study
Racecadotril for acute diarrhoea in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Immunization Schedule; 2. Injections, Intradermal; 3. Injections, Intramuscular; 4. Poliomyelitis [*prevention & control]; 5. Poliovirus [*immunology]; 6. Poliovirus Vaccine, Inactivated [administration & dosage, immunology]; 7. Poliovirus Vaccine, Oral [*administration & dosage, immunology]; 8. Randomized Controlled Trials as Topic; 9. Vaccination [methods]; | Provide MESH terms for the study
Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Pseudomonas aeruginosa; 2. Administration, Inhalation; 3. Anti‐Bacterial Agents [*therapeutic use]; 4. Cystic Fibrosis [*complications]; 5. Forced Expiratory Volume; 6. Pseudomonas Infections [*complications, drug therapy, *prevention & control]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Recurrence; 10. Secondary Prevention; 11. Tobramycin [therapeutic use]; | Provide MESH terms for the study
Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Antibiotic Prophylaxis; 2. Abdominal Injuries [complications, *drug therapy]; 3. Anti‐Bacterial Agents [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Time Factors; 6. Wound Infection [*prevention & control]; 7. Wounds, Penetrating [complications, *drug therapy]; | Provide MESH terms for the study
Prophylactic antibiotics for penetrating abdominal trauma: duration of use and antibiotic choice | You are a research assistant. Based on the question please provide appropriate answers |
1. Chewing Gum; 2. Chlorhexidine [therapeutic use]; 3. Dental Scaling; 4. Halitosis [*therapy]; 5. Mouthwashes [*therapeutic use]; 6. Oral Health; 7. Oral Hygiene [*methods]; 8. Randomized Controlled Trials as Topic; 9. Tongue [microbiology]; 10. Toothbrushing [methods]; 11. Toothpastes; | Provide MESH terms for the study
Interventions for managing halitosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Neuroprotective Agents [*therapeutic use]; 2. Oligonucleotides [*therapeutic use]; 3. Randomized Controlled Trials as Topic; 4. Spinal Muscular Atrophies of Childhood [*drug therapy]; | Provide MESH terms for the study
Drug treatment for spinal muscular atrophy type I | You are a research assistant. Based on the question please provide appropriate answers |
1. *Preoperative Care; 2. Anemia, Iron‐Deficiency [prevention & control, *therapy]; 3. Iron, Dietary [*administration & dosage]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Iron therapy for preoperative anaemia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bites and Stings; 2. *Wound Healing; 3. Randomized Controlled Trials as Topic; 4. Soft Tissue Injuries [*therapy]; 5. Wound Infection [*epidemiology, prevention & control]; | Provide MESH terms for the study
Primary closure versus delayed or no closure for traumatic wounds due to mammalian bite | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [adverse effects, *therapeutic use]; 2. Hospital Mortality; 3. Length of Stay; 4. Randomized Controlled Trials as Topic; 5. Risk Factors; 6. Sepsis [*drug therapy, *mortality]; 7. Time Factors; | Provide MESH terms for the study
Corticosteroids for treating sepsis in children and adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Education of Intellectually Disabled; 2. *Reading; 3. Intellectual Disability [*psychology]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Beginning reading interventions for children and adolescents with intellectual disability | You are a research assistant. Based on the question please provide appropriate answers |
1. Adverse Drug Reaction Reporting Systems; 2. Immunity, Mucosal; 3. Immunization Schedule; 4. Interrupted Time Series Analysis; 5. Poliomyelitis [*prevention & control]; 6. Poliovirus [immunology]; 7. Poliovirus Vaccine, Inactivated [*administration & dosage, *adverse effects]; 8. Poliovirus Vaccine, Oral [*administration & dosage, *adverse effects]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Colic [*therapy]; 2. Parents [*education, psychology]; 3. Randomized Controlled Trials as Topic; 4. Stress, Psychological; | Provide MESH terms for the study
Parent training programmes for managing infantile colic | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [therapeutic use]; 2. Epilepsy [*drug therapy]; 3. Immunoglobulins, Intravenous [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Seizures [drug therapy]; 6. Treatment Outcome; | Provide MESH terms for the study
Intravenous immunoglobulins for epilepsy | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.